The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
127043101 12704310 1 I 20160824 20160831 20160831 EXP DE-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2016-BI-55852BI BOEHRINGER INGELHEIM GENERALISED SEIZURES WITH LETHAL COMPLICATIONS: CASE REPORT. -- 2016 AUG 23;. 76.00 YR F Y 0.00000 20160831 OT COUNTRY NOT SPECIFIED DE

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
127043101 12704310 1 PS PRADAXA DABIGATRAN ETEXILATE MESYLATE 1 Unknown 220 MG U 22512 110 MG BID
127043101 12704310 2 SS OLANZAPINE. OLANZAPINE 1 Unknown 0 5 MG
127043101 12704310 3 SS OLANZAPINE. OLANZAPINE 1 Unknown 0 2.5 MG
127043101 12704310 4 SS PREDNISOLONE. PREDNISOLONE 1 Unknown 5 MG U 0 5 MG QD
127043101 12704310 5 SS METHOTREXATE. METHOTREXATE 1 Unknown 2.1429 MG U 0 15 MG /wk
127043101 12704310 6 SS VENLAFAXINE VENLAFAXINE HYDROCHLORIDE 1 Unknown FORMULATION: EXTENDED RELEASE U 0 37.5 MG
127043101 12704310 7 SS VENLAFAXINE VENLAFAXINE HYDROCHLORIDE 1 Unknown FORMULATION: EXTENDED RELEASE U 0 75 MG
127043101 12704310 8 C AMITRIPTYLINE AMITRIPTYLINE 1 Unknown 0 30 MG
127043101 12704310 9 C DOXEPIN DOXEPIN 1 Unknown 0 25 MG

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
127043101 12704310 1 Deep vein thrombosis
127043101 12704310 2 Insomnia
127043101 12704310 3 Depressed mood
127043101 12704310 4 Rheumatoid arthritis
127043101 12704310 5 Rheumatoid arthritis
127043101 12704310 6 Antidepressant therapy
127043101 12704310 8 Sleep disorder
127043101 12704310 9 Sleep disorder

Outcome of event

Event ID CASEID OUTC COD
127043101 12704310 OT
127043101 12704310 DE
127043101 12704310 HO

Reactions reported

Event ID CASEID DRUG REC ACT PT
127043101 12704310 Circulatory collapse
127043101 12704310 Femoral neck fracture
127043101 12704310 General physical health deterioration
127043101 12704310 Generalised tonic-clonic seizure
127043101 12704310 Haematoma
127043101 12704310 Iron deficiency anaemia
127043101 12704310 Patella fracture
127043101 12704310 Tibia fracture
127043101 12704310 Ulna fracture

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

no results found